Skip to main content

SGI Japan Forms Genomic Database Partnership With Xanagen

NEW YORK, Dec. 29 (GenomeWeb News) - SGI Japan and Japanese Bio company Xanagen have formed a microbial genome database strategic alliance, Japan Corporate News Network reported last week.


Under the deal, the companies will combine Xanagen's XanaGenome integrated database with SGI's PDFAMS Base protein structure database, said JCNN.


Additional details were not available.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.